Replimune
Develops immunotherapies for cancer treatment
Replimune has raised €27M across 1 funding round from 2 investors, most recently a Series A round in Sep 2015. Based in Oxford, UK; founded 2015; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€27M
€26,749,889
Funding rounds
1
Investors
2
distinct backers
Active since
2015-09
latest 2015-09
Funding by year
EUR raised per yearReplimune — funding by year — interactive chart.
Data table
| Replimune — funding by year | |
|---|---|
| 2015 | €27M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-09-01 | Series A | €27M | Atlas Venture,Forbion | View deal → |